ATA782177A - Verfahren zur herstellung von neuen cis-4a-aryloctahydro-1h-2-pyrindin-verbindungen sowie der ungiftigen pharmazeutisch annehmbaren saeuread- ditionssalze davon - Google Patents

Verfahren zur herstellung von neuen cis-4a-aryloctahydro-1h-2-pyrindin-verbindungen sowie der ungiftigen pharmazeutisch annehmbaren saeuread- ditionssalze davon

Info

Publication number
ATA782177A
ATA782177A AT0782177A AT782177A ATA782177A AT A782177 A ATA782177 A AT A782177A AT 0782177 A AT0782177 A AT 0782177A AT 782177 A AT782177 A AT 782177A AT A782177 A ATA782177 A AT A782177A
Authority
AT
Austria
Prior art keywords
aryloctahydro
pyrindine
compounds
pharmaceutically acceptable
acid addition
Prior art date
Application number
AT0782177A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ATA782177A publication Critical patent/ATA782177A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/757Unsaturated compounds containing a keto groups being part of a ring containing —CHO groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AT0782177A 1976-11-02 1977-11-02 Verfahren zur herstellung von neuen cis-4a-aryloctahydro-1h-2-pyrindin-verbindungen sowie der ungiftigen pharmazeutisch annehmbaren saeuread- ditionssalze davon ATA782177A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73795876A 1976-11-02 1976-11-02

Publications (1)

Publication Number Publication Date
ATA782177A true ATA782177A (de) 1981-10-15

Family

ID=24965981

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0782177A ATA782177A (de) 1976-11-02 1977-11-02 Verfahren zur herstellung von neuen cis-4a-aryloctahydro-1h-2-pyrindin-verbindungen sowie der ungiftigen pharmazeutisch annehmbaren saeuread- ditionssalze davon

Country Status (26)

Country Link
JP (1) JPS5356669A (de)
AR (1) AR223454A1 (de)
AT (1) ATA782177A (de)
AU (1) AU513679B2 (de)
BE (1) BE860314A (de)
CA (1) CA1100136A (de)
CS (1) CS211380B2 (de)
DD (1) DD133795A5 (de)
DE (1) DE2748466A1 (de)
DK (1) DK485277A (de)
ES (3) ES463783A1 (de)
FR (1) FR2369267A1 (de)
GB (1) GB1590155A (de)
GR (1) GR70053B (de)
HU (1) HU176231B (de)
IE (1) IE45901B1 (de)
IL (1) IL53236A0 (de)
NL (1) NL7712053A (de)
NZ (1) NZ185539A (de)
PH (1) PH12590A (de)
PL (3) PL109690B1 (de)
PT (1) PT67194B (de)
RO (3) RO78300A (de)
SE (3) SE7712218L (de)
SU (3) SU812174A3 (de)
ZA (1) ZA776497B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ189230A (en) * 1977-12-27 1981-05-15 Lilly Co Eli Trans-4a-aryl-2-substituted-octahydro-1h-2-pyrindines
US4277608A (en) * 1979-06-21 1981-07-07 Eli Lilly And Company Method of preparing 4a-arylhexahydro-1H-2-pyrindines and 4a-aryloctahydroisoquinolines
US4236009A (en) * 1979-06-21 1980-11-25 Eli Lilly And Company Method of preparing 4A-arylhexahydro-1H-2-pyrindines and 4A-aryloctahydroisoquinolines
ZA9510829B (en) * 1994-12-23 1996-07-03 Smithkline Beecham Corp 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds
WO2011140425A1 (en) 2010-05-06 2011-11-10 Vertex Pharmaceuticals Incorporated Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
PT2670752E (pt) 2011-02-02 2016-06-14 Vertex Pharma Piperidinamidas pirrolopirazina-espirocíclicas como moduladores de canais iónicos
WO2012112743A1 (en) 2011-02-18 2012-08-23 Vertex Pharmaceuticals Incorporated Chroman - spirocyclic piperidine amides as modulators of ion channels
MX347982B (es) 2011-03-14 2017-05-22 Vertex Pharma Morfolina-piperidina espirociclica-amidas como moduladores de canales ionicos.

Also Published As

Publication number Publication date
AR223454A1 (es) 1981-08-31
JPS5356669A (en) 1978-05-23
PL108466B1 (en) 1980-04-30
IE45901L (en) 1978-05-02
CS211380B2 (en) 1982-02-26
PL201885A1 (pl) 1978-12-04
DE2748466A1 (de) 1978-05-03
BE860314A (fr) 1978-04-28
SE7712218L (sv) 1978-05-03
SU845777A3 (ru) 1981-07-07
HU176231B (en) 1981-01-28
PT67194A (en) 1977-11-01
RO78300A (ro) 1982-04-12
ES472276A1 (es) 1979-10-01
SU812174A3 (ru) 1981-03-07
NL7712053A (nl) 1978-05-05
GB1590155A (en) 1981-05-28
PL108610B1 (en) 1980-04-30
RO77935A (ro) 1981-12-25
FR2369267A1 (fr) 1978-05-26
ZA776497B (en) 1979-06-27
ES463784A1 (es) 1978-06-16
NZ185539A (en) 1979-12-11
IL53236A0 (en) 1977-12-30
IE45901B1 (en) 1982-12-29
SE8103107L (sv) 1981-05-18
PT67194B (en) 1979-03-23
AU3023577A (en) 1979-05-10
SU913941A3 (en) 1982-03-15
DK485277A (da) 1978-05-03
RO72900A (ro) 1981-11-04
SE8103106L (sv) 1981-05-18
GR70053B (de) 1982-07-26
ES463783A1 (es) 1979-07-16
FR2369267B1 (de) 1980-05-16
PL109690B1 (en) 1980-06-30
AU513679B2 (en) 1980-12-18
CA1100136A (en) 1981-04-28
DD133795A5 (de) 1979-01-24
PH12590A (en) 1979-06-27

Similar Documents

Publication Publication Date Title
AT359488B (de) Verfahren zur herstellung von neuen phthalan- -derivaten und ihren pharmazeutisch annehm- baren saeureadditionssalzen
AT357143B (de) Verfahren zur herstellung von neuen substi- tuierten 3-phenoxy-2-hydroxy-1-aminopropanen sowie deren saeureadditionssalzen
AT363465B (de) Verfahren zur herstellung von neuen 5-aroyl-1,2 -dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1-carbonsaeureestern und -salzen
AT367430B (de) Verfahren zur herstellung von neuen hydroxylamino-hydrocarbylphosphonsaeurederivaten
AT358035B (de) Verfahren zur herstellung von neuen indolizin- derivaten und von ihren saeureadditionssalzen
AT360533B (de) Verfahren zur herstellung von neuen trans- -hexahydropyrido-indolen und ihren saeure- additionssalzen
AT359522B (de) Verfahren zur herstellung von neuen 6-amino- alkylaminouracilen sowie deren saeureadditions- salzen
AT354436B (de) Verfahren zur herstellung von neuem 2-brom-6- fluor-n-2-imidazolidinyliden-benzamin und dessen saeureadditionssalzen
AT373580B (de) Verfahren zur herstellung von neuen substituierten 2-benzylpyrrolidinen, ihren quaternaeren alkylverbindungen und ihren saeureadditionssalzen
ATA782177A (de) Verfahren zur herstellung von neuen cis-4a-aryloctahydro-1h-2-pyrindin-verbindungen sowie der ungiftigen pharmazeutisch annehmbaren saeuread- ditionssalze davon
AT356110B (de) Verfahren zur herstellung von neuen benzyliso- chinolinderivaten und ihren saeureadditions- salzen
AT361904B (de) Verfahren zur herstellung von neuen 3-anilino- aethylamino-2-hydroxy-1-phenoxypropanen sowie deren saeureadditionssalzen
AT363928B (de) Verfahren zur herstellung von neuen hydrazonverbindungen und von pharmakologisch vertraeglichen saeureadditionssalzen und quaternaeren ammoniumsalzen derselben
AT359521B (de) Verfahren zur herstellung von neuen isothio- harnstoffaminoalkylaethern sowie von deren salzen
AT353960B (de) Verfahren zur herstellung von neuen bis-peni- cillanoyloxy-alkanen und deren pharmazeutisch annehmbaren salzen
AT365170B (de) Verfahren zur herstellung von neuen 13-thiaprostansaeurederivaten
AT360029B (de) Verfahren zur herstellung von neuen 2,4-diamino -5-thiobenzylpyrimidinen und ihren saeure- additionssalzen
AT358046B (de) Verfahren zur herstellung von neuen trans-5a- -aryl-decahydrobenzazepinen und ihren saeure- additionssalzen
ATA392379A (de) Verfahren zur herstellung von neuen benzo(c)-chinolinen und deren pharmazeutisch vertraeglichen saeureadditionssalzen
ATA162476A (de) Verfahren zur herstellung von neuen phenoxy- phenylbuttersaeure-derivaten sowie von ihren salzen
AT357692B (de) Verfahren zur herstellung von 4-desacetoxy- -vinblastin und dessen saeureadditionssalzen
AT360675B (de) Verfahren zur herstellung von neuen tetradecapeptiden und ihren pharmazeutisch annehmbaren nichttoxischen saeureadditionssalzen
ATA95279A (de) Verfahren zur herstellung von neuen indolizin- derivaten und von ihren saeureadditionssalzen
ATA59280A (de) Verfahren zur herstellung von neuen 3-anilinoaethylamino-2-hydroxy-1-phenoxypropanen sowie deren saeureadditionssalzen
AT363941B (de) Verfahren zur herstellung von neuen aminoalkylheterocyclen und ihren saeureadditionssalzen

Legal Events

Date Code Title Description
A1AW Revocation of published examined application